NIAID Funding Opportunity: Advancing Cancer Immunotherapy by Mitigating Immune-Related Adverse Events

Funding Opportunity

• RFA-CA-19-044, Advancing Cancer Immunotherapy by Mitigating Immune-Related Adverse Events (irAE) (U01, Clinical Trial Not Allowed)

For more, see Opportunities & Announcements. 

You can follow us on Twitter: @NIAIDFunding.